Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
6.07
-2.46 (-28.84%)
Jun 1, 2026, 1:31 PM EDT - Market open
Co-Diagnostics Employees
Co-Diagnostics had 115 employees as of December 31, 2025. The number of employees decreased by 17 or -12.88% compared to the previous year.
Employees
115
Change (1Y)
-17
Growth (1Y)
-12.88%
Revenue / Employee
$6,245
Profits / Employee
-$421,763
Market Cap
22.20M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 115 | -17 | -12.88% |
| Dec 31, 2024 | 132 | -23 | -14.84% |
| Dec 31, 2023 | 155 | 10 | 6.90% |
| Dec 31, 2022 | 145 | 44 | 43.56% |
| Dec 31, 2021 | 101 | 62 | 158.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 990 |
| Nortech Systems | 713 |
| TELA Bio | 218 |
| Myomo | 195 |
| Cytosorbents | 129 |
| InspireMD | 127 |
| Lifeward | 81 |
| Pulsenmore | 71 |
CODX News
- 3 days ago - Co-Diagnostics files to sell 4.94M shares of common stock for holders - TheFly
- 4 days ago - Co-Diagnostics Registration statement: Registration filing - Filings
- 5 days ago - Co-Diagnostics trading halted, volatility trading pause - TheFly
- 5 days ago - Co-Diagnostics trading resumes - TheFly
- 6 days ago - Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development - TheFly
- 6 days ago - Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara - PRNewsWire
- 12 days ago - Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 13 days ago - Co-Diagnostics develops ebola assay strategy after recent global outbreak alert - TheFly